These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
682 related articles for article (PubMed ID: 23907978)
1. Enhanced photodynamic efficiency of an aptamer-guided fullerene photosensitizer toward tumor cells. Liu Q; Xu L; Zhang X; Li N; Zheng J; Guan M; Fang X; Wang C; Shu C Chem Asian J; 2013 Oct; 8(10):2370-6. PubMed ID: 23907978 [TBL] [Abstract][Full Text] [Related]
2. Structural effect and mechanism of C70-carboxyfullerenes as efficient sensitizers against cancer cells. Liu Q; Guan M; Xu L; Shu C; Jin C; Zheng J; Fang X; Yang Y; Wang C Small; 2012 Jul; 8(13):2070-7. PubMed ID: 22508680 [TBL] [Abstract][Full Text] [Related]
3. Effect and mechanism of a new photodynamic therapy with glycoconjugated fullerene. Otake E; Sakuma S; Torii K; Maeda A; Ohi H; Yano S; Morita A Photochem Photobiol; 2010; 86(6):1356-63. PubMed ID: 20796243 [TBL] [Abstract][Full Text] [Related]
4. A tumoral acidic pH-responsive drug delivery system based on a novel photosensitizer (fullerene) for in vitro and in vivo chemo-photodynamic therapy. Shi J; Liu Y; Wang L; Gao J; Zhang J; Yu X; Ma R; Liu R; Zhang Z Acta Biomater; 2014 Mar; 10(3):1280-91. PubMed ID: 24211343 [TBL] [Abstract][Full Text] [Related]
5. Aptamer-Targeted Photodynamic Platforms for Tumor Therapy. Yan J; Gao T; Lu Z; Yin J; Zhang Y; Pei R ACS Appl Mater Interfaces; 2021 Jun; 13(24):27749-27773. PubMed ID: 34110790 [TBL] [Abstract][Full Text] [Related]
6. C-MYC and C-FOS expression changes and cellular aspects of the photodynamic reaction with photosensitizers TMPyP and ClAlPcS2. Pizova K; Bajgar R; Fillerova R; Kriegova E; Cenklova V; Langova K; Konecny P; Kolarova H J Photochem Photobiol B; 2015 Jan; 142():186-96. PubMed ID: 25545333 [TBL] [Abstract][Full Text] [Related]
8. Special reactive oxygen species generation by a highly photostable BODIPY-based photosensitizer for selective photodynamic therapy. Lai YC; Su SY; Chang CC ACS Appl Mater Interfaces; 2013 Dec; 5(24):12935-43. PubMed ID: 24313397 [TBL] [Abstract][Full Text] [Related]
9. Angiogenin-mediated photosensitizer-aptamer conjugate for photodynamic therapy. Yang X; Huang J; Wang K; Li W; Cui L; Li X ChemMedChem; 2011 Oct; 6(10):1778-80. PubMed ID: 21774079 [No Abstract] [Full Text] [Related]
10. Aptamer/photosensitizer hybridized mesoporous MnO Liu W; Zhang K; Zhuang L; Liu J; Zeng W; Shi J; Zhang Z Colloids Surf B Biointerfaces; 2019 Dec; 184():110536. PubMed ID: 31639567 [TBL] [Abstract][Full Text] [Related]
11. Graphene oxide-fullerene C Li Q; Hong L; Li H; Liu C Biosens Bioelectron; 2017 Mar; 89(Pt 1):477-482. PubMed ID: 27055602 [TBL] [Abstract][Full Text] [Related]
12. Metal-Organic Frameworks with Enhanced Photodynamic Therapy: Synthesis, Erythrocyte Membrane Camouflage, and Aptamer-Targeted Aggregation. Zhao Y; Wang J; Cai X; Ding P; Lv H; Pei R ACS Appl Mater Interfaces; 2020 May; 12(21):23697-23706. PubMed ID: 32362109 [TBL] [Abstract][Full Text] [Related]
13. Study of the photodynamic effect on the A549 cell line by atomic force microscopy and the influence of green tea extract on the production of reactive oxygen species. Tomankova K; Kolarova H; Bajgar R; Jirova D; Kejlova K; Mosinger J Ann N Y Acad Sci; 2009 Aug; 1171():549-58. PubMed ID: 19723103 [TBL] [Abstract][Full Text] [Related]
14. Pro-oxidant and Antioxidant Effects in Photodynamic Therapy: Cells Recognise that Not All Exogenous ROS Are Alike. Soares HT; Campos JR; Gomes-da-Silva LC; Schaberle FA; Dabrowski JM; Arnaut LG Chembiochem; 2016 May; 17(9):836-42. PubMed ID: 26891856 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of photodynamic therapy (PDT) procedures using microfluidic system. Jedrych E; Pawlicka Z; Chudy M; Dybko A; Brzozka Z Anal Chim Acta; 2011 Jan; 683(2):149-55. PubMed ID: 21167965 [TBL] [Abstract][Full Text] [Related]
16. Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers. Doshi M; Gesquiere AJ J Vis Exp; 2015 Oct; (105):e53038. PubMed ID: 26556528 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and photocytotoxicity of structure-defined water-soluble C60/micelle supramolecular nanoparticles. Metanawin T; Tang T; Chen R; Vernon D; Wang X Nanotechnology; 2011 Jun; 22(23):235604. PubMed ID: 21483045 [TBL] [Abstract][Full Text] [Related]
18. Lanthanide-doped upconversion nanoparticles electrostatically coupled with photosensitizers for near-infrared-triggered photodynamic therapy. Wang M; Chen Z; Zheng W; Zhu H; Lu S; Ma E; Tu D; Zhou S; Huang M; Chen X Nanoscale; 2014 Jul; 6(14):8274-82. PubMed ID: 24933297 [TBL] [Abstract][Full Text] [Related]
19. The activity of G-ROS and the predominant role of Type II reaction in the photodynamic therapy using 9-hydroxypheophorbide-α for HeLa cell lines. Ahn JC; Chung PS Gen Physiol Biophys; 2012 Sep; 31(3):343-50. PubMed ID: 23047947 [TBL] [Abstract][Full Text] [Related]
20. UV-emitting upconversion-based TiO2 photosensitizing nanoplatform: near-infrared light mediated in vivo photodynamic therapy via mitochondria-involved apoptosis pathway. Hou Z; Zhang Y; Deng K; Chen Y; Li X; Deng X; Cheng Z; Lian H; Li C; Lin J ACS Nano; 2015 Mar; 9(3):2584-99. PubMed ID: 25692960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]